Free Trial

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.74 -0.11 (-12.94%)
As of 02/21/2025 11:59 AM Eastern

KNB vs. TLY, SPI, MGP, SBI, AKR, POLX, SNG, AOR, IMM, and AREC

Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Akers Biosciences (AKR), Polarean Imaging (POLX), Synairgen (SNG), AorTech International (AOR), ImmuPharma (IMM), and Arecor Therapeutics (AREC). These companies are all part of the "medical" sector.

Kanabo Group vs.

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, community ranking, analyst recommendations and institutional ownership.

In the previous week, Totally and Totally both had 1 articles in the media. Totally's average media sentiment score of 0.15 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Totally
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Totally has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.05-£3.79M-£1.93-1.91
Kanabo Group£1.14M4.11-£8.18M-£1.29-0.57

51.3% of Totally shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 13.3% of Totally shares are owned by company insiders. Comparatively, 37.0% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%
Kanabo GroupN/AN/A

Totally currently has a consensus target price of GBX 20, indicating a potential upside of 443.48%. Given Totally's stronger consensus rating and higher possible upside, research analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.85% -11.01% -2.42%
Kanabo Group -717.63%-121.77%-20.89%

Summary

Totally beats Kanabo Group on 11 of the 16 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£4.68M£1.49B£5.84B£2.64B
Dividend YieldN/A3.83%4.75%4.98%
P/E Ratio-0.577.1826.04162.45
Price / Sales4.1132.73447.46313,322.68
Price / Cash1.8212.5138.0128.12
Price / Book0.792.007.645.16
Net Income-£8.18M£58.65M£3.18B£5.75B
7 Day Performance-15.33%-1.30%-2.00%-0.99%
1 Month Performance-17.78%-0.19%-0.44%-0.80%
1 Year Performance-61.05%6.64%16.44%39.55%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.74
-12.9%
N/A-61.1%£4.68M£1.14M-0.5720News Coverage
Gap Down
High Trading Volume
TLY
Totally
2.6981 of 5 stars
GBX 4.65
-2.1%
GBX 20
+330.1%
-39.9%£9.14M£133.05M-2.411,668News Coverage
High Trading Volume
SPI
Spire Healthcare Group
1.7042 of 5 stars
GBX 228.90
0.0%
GBX 322
+40.7%
-4.4%£919.18M£1.44B32.58420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
POLX
Polarean Imaging
N/AGBX 1.42
-3.9%
N/A-78.9%£20.81M£5.21M-0.3628
SNG
Synairgen
N/AGBX 2.06
-8.4%
N/A-59.4%£20.14MN/A-1.2434Gap Down
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539,000.00-33.383
IMM
ImmuPharma
N/AGBX 4.65
+8.0%
N/A+259.0%£19.77M£-71,310.29-8.0413
AREC
Arecor Therapeutics
N/AGBX 52
-4.6%
N/A-64.7%£19.63M£6.04M-1.8410Gap Down

Related Companies and Tools


This page (LON:KNB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners